Cat.#: ACPP-1450
| Despition | BMP13 Human Recombinant |
| SIZE | 10 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1657 | Human CRCP Protein (AC1657) | 5 µg | inquiry |
| ACPP-1750 | Human LCN1 Protein (AC1750) | 5 µg | inquiry |
| ACPP-1216 | PARD3 Blocking Peptide (AC1216) | 250 µg | inquiry |
| ACPP-1287 | Dopamine Receptor D1 Blocking Peptide (AC1287) | 250 µg | inquiry |
| ACPP-1569 | Human SOX2 Protein (AC1569) | 5 µg | inquiry |
| ACPP-1460 | Mouse GMFB Protein (AC1460) | 2 µg | inquiry |
| ACPP-1330 | PAX2 Blocking Peptide (AC1330) | 250 µg | inquiry |
| ACPP-1082 | Human CACYBP Protein (AC1082) | 5 µg | inquiry |
| ACPP-1307 | NPY2R Blocking Peptide (AC1307) | 250 µg | inquiry |
| ACPP-1795 | Human STXBP6 Protein (AC1795) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.